Concepts (157)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cholestasis | 8 | 2024 | 59 | 3.120 |
Why?
|
| Capsule Endoscopy | 9 | 2021 | 35 | 2.900 |
Why?
|
| Artificial Intelligence | 5 | 2024 | 163 | 2.360 |
Why?
|
| Endosonography | 7 | 2024 | 26 | 2.350 |
Why?
|
| Pancreatic Neoplasms | 5 | 2024 | 340 | 2.000 |
Why?
|
| Bile Duct Neoplasms | 3 | 2024 | 46 | 1.750 |
Why?
|
| Endoscopy, Gastrointestinal | 16 | 2024 | 74 | 1.530 |
Why?
|
| Endoscopy, Digestive System | 4 | 2024 | 27 | 1.240 |
Why?
|
| Laparoscopy | 2 | 2024 | 472 | 1.220 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 8 | 2024 | 47 | 1.200 |
Why?
|
| Gastrointestinal Hemorrhage | 6 | 2021 | 79 | 1.180 |
Why?
|
| Drainage | 2 | 2024 | 154 | 1.050 |
Why?
|
| Gastroesophageal Reflux | 2 | 2024 | 92 | 0.980 |
Why?
|
| Cholecystectomy | 1 | 2024 | 34 | 0.900 |
Why?
|
| Cholecystitis | 1 | 2024 | 29 | 0.890 |
Why?
|
| Cholecystostomy | 1 | 2024 | 22 | 0.890 |
Why?
|
| Constriction, Pathologic | 8 | 2025 | 121 | 0.860 |
Why?
|
| Endoscopes | 2 | 2020 | 7 | 0.840 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2024 | 178 | 0.820 |
Why?
|
| Barotrauma | 1 | 2023 | 3 | 0.820 |
Why?
|
| Celiac Plexus | 3 | 2024 | 3 | 0.800 |
Why?
|
| Hemostatics | 1 | 2023 | 26 | 0.800 |
Why?
|
| Duodenal Obstruction | 1 | 2021 | 4 | 0.740 |
Why?
|
| Obesity, Morbid | 1 | 2022 | 97 | 0.720 |
Why?
|
| Gastroenterology | 1 | 2021 | 42 | 0.680 |
Why?
|
| Disinfection | 1 | 2020 | 22 | 0.670 |
Why?
|
| Humans | 41 | 2025 | 62947 | 0.650 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2020 | 111 | 0.630 |
Why?
|
| Infection Control | 1 | 2020 | 106 | 0.630 |
Why?
|
| Cross Infection | 1 | 2020 | 160 | 0.610 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 297 | 0.550 |
Why?
|
| Abdominal Cavity | 1 | 2014 | 6 | 0.440 |
Why?
|
| Endoscopic Mucosal Resection | 2 | 2023 | 4 | 0.420 |
Why?
|
| Radiographic Image Enhancement | 1 | 2014 | 98 | 0.420 |
Why?
|
| Prospective Studies | 5 | 2022 | 3262 | 0.400 |
Why?
|
| Intestine, Small | 3 | 2025 | 79 | 0.400 |
Why?
|
| Enteritis | 2 | 2025 | 14 | 0.400 |
Why?
|
| Ergonomics | 2 | 2023 | 79 | 0.400 |
Why?
|
| Stomach Neoplasms | 2 | 2023 | 78 | 0.400 |
Why?
|
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 2 | 2024 | 15 | 0.390 |
Why?
|
| Esophageal Neoplasms | 2 | 2023 | 83 | 0.390 |
Why?
|
| Pancreatitis | 2 | 2022 | 97 | 0.380 |
Why?
|
| Suture Techniques | 2 | 2024 | 99 | 0.380 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 287 | 0.370 |
Why?
|
| Standard of Care | 3 | 2019 | 27 | 0.350 |
Why?
|
| Liver Transplantation | 2 | 2023 | 215 | 0.340 |
Why?
|
| Adenocarcinoma | 2 | 2023 | 338 | 0.340 |
Why?
|
| Pancreas | 2 | 2020 | 150 | 0.320 |
Why?
|
| Colonoscopy | 2 | 2018 | 97 | 0.280 |
Why?
|
| Gastrostomy | 2 | 2024 | 29 | 0.280 |
Why?
|
| Ulcer | 2 | 2025 | 14 | 0.280 |
Why?
|
| Nerve Block | 2 | 2024 | 51 | 0.270 |
Why?
|
| Gastrectomy | 2 | 2024 | 40 | 0.250 |
Why?
|
| Middle Aged | 10 | 2025 | 17408 | 0.230 |
Why?
|
| Aged | 10 | 2025 | 14286 | 0.230 |
Why?
|
| Bile Ducts | 1 | 2024 | 25 | 0.230 |
Why?
|
| Intestinal Obstruction | 1 | 2025 | 53 | 0.230 |
Why?
|
| Pancreatitis, Chronic | 1 | 2024 | 19 | 0.230 |
Why?
|
| Cytodiagnosis | 1 | 2024 | 46 | 0.220 |
Why?
|
| Enteral Nutrition | 1 | 2024 | 54 | 0.220 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2024 | 44 | 0.220 |
Why?
|
| Diagnosis, Differential | 3 | 2025 | 968 | 0.220 |
Why?
|
| Catheterization | 1 | 2024 | 111 | 0.210 |
Why?
|
| Crohn Disease | 1 | 2025 | 111 | 0.210 |
Why?
|
| Powders | 1 | 2023 | 20 | 0.210 |
Why?
|
| Minerals | 1 | 2023 | 20 | 0.200 |
Why?
|
| Hemostasis | 1 | 2023 | 18 | 0.200 |
Why?
|
| Treatment Outcome | 5 | 2024 | 5608 | 0.200 |
Why?
|
| Stents | 5 | 2024 | 487 | 0.200 |
Why?
|
| Male | 11 | 2025 | 29603 | 0.190 |
Why?
|
| Feasibility Studies | 1 | 2024 | 562 | 0.180 |
Why?
|
| Anastomosis, Surgical | 1 | 2021 | 112 | 0.180 |
Why?
|
| Pilot Projects | 1 | 2024 | 990 | 0.180 |
Why?
|
| Internet | 1 | 2024 | 466 | 0.170 |
Why?
|
| Female | 10 | 2025 | 32597 | 0.170 |
Why?
|
| Duodenoscopes | 1 | 2020 | 2 | 0.170 |
Why?
|
| Fomites | 1 | 2020 | 4 | 0.170 |
Why?
|
| Area Under Curve | 1 | 2020 | 146 | 0.170 |
Why?
|
| Oxycodone | 1 | 2020 | 30 | 0.170 |
Why?
|
| Observer Variation | 1 | 2020 | 211 | 0.170 |
Why?
|
| Celiac Disease | 1 | 2020 | 15 | 0.170 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2019 | 4 | 0.160 |
Why?
|
| ROC Curve | 1 | 2020 | 280 | 0.160 |
Why?
|
| Disease Outbreaks | 1 | 2020 | 115 | 0.160 |
Why?
|
| Pancreatic Cyst | 1 | 2019 | 24 | 0.160 |
Why?
|
| Fentanyl | 1 | 2020 | 76 | 0.160 |
Why?
|
| Research | 1 | 2021 | 192 | 0.160 |
Why?
|
| Desiccation | 1 | 2019 | 6 | 0.160 |
Why?
|
| Filtration | 1 | 2019 | 20 | 0.160 |
Why?
|
| Decontamination | 1 | 2019 | 12 | 0.160 |
Why?
|
| Hematemesis | 1 | 2018 | 6 | 0.150 |
Why?
|
| Machine Learning | 1 | 2020 | 175 | 0.150 |
Why?
|
| Melena | 1 | 2018 | 5 | 0.150 |
Why?
|
| Delayed Diagnosis | 1 | 2018 | 45 | 0.150 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2019 | 108 | 0.150 |
Why?
|
| Guideline Adherence | 1 | 2020 | 306 | 0.140 |
Why?
|
| Retrospective Studies | 7 | 2025 | 6565 | 0.140 |
Why?
|
| Early Diagnosis | 1 | 2018 | 97 | 0.140 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 1141 | 0.140 |
Why?
|
| Arteriovenous Malformations | 1 | 2017 | 43 | 0.140 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 419 | 0.130 |
Why?
|
| Anemia | 1 | 2018 | 127 | 0.130 |
Why?
|
| Aged, 80 and over | 4 | 2024 | 5418 | 0.130 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 729 | 0.130 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 934 | 0.120 |
Why?
|
| Analgesics, Opioid | 1 | 2020 | 533 | 0.120 |
Why?
|
| Logistic Models | 1 | 2018 | 1273 | 0.110 |
Why?
|
| Time Factors | 2 | 2018 | 3752 | 0.110 |
Why?
|
| Software | 1 | 2014 | 384 | 0.080 |
Why?
|
| Risk Factors | 4 | 2023 | 5313 | 0.080 |
Why?
|
| Multiple System Atrophy | 1 | 2008 | 13 | 0.080 |
Why?
|
| Dermis | 1 | 2008 | 18 | 0.080 |
Why?
|
| Parkinson Disease | 1 | 2008 | 129 | 0.070 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2025 | 22 | 0.060 |
Why?
|
| Fundoplication | 1 | 2024 | 25 | 0.060 |
Why?
|
| Calculi | 1 | 2024 | 2 | 0.060 |
Why?
|
| Choledochostomy | 1 | 2024 | 3 | 0.060 |
Why?
|
| Biliary Tract Neoplasms | 1 | 2024 | 9 | 0.060 |
Why?
|
| Pancreatic Pseudocyst | 1 | 2024 | 12 | 0.060 |
Why?
|
| Hernia, Hiatal | 1 | 2024 | 26 | 0.060 |
Why?
|
| Proton Pump Inhibitors | 1 | 2024 | 42 | 0.060 |
Why?
|
| Lithotripsy | 1 | 2024 | 10 | 0.060 |
Why?
|
| Biliary Tract Diseases | 1 | 2024 | 16 | 0.060 |
Why?
|
| Pancreatic Ducts | 1 | 2024 | 30 | 0.060 |
Why?
|
| Self Expandable Metallic Stents | 1 | 2024 | 33 | 0.060 |
Why?
|
| Deglutition Disorders | 1 | 2024 | 42 | 0.060 |
Why?
|
| United States | 3 | 2023 | 7760 | 0.060 |
Why?
|
| Cholecystitis, Acute | 1 | 2024 | 30 | 0.050 |
Why?
|
| Needles | 1 | 2024 | 67 | 0.050 |
Why?
|
| Gastric Bypass | 1 | 2024 | 76 | 0.050 |
Why?
|
| Ultrasonography, Interventional | 1 | 2024 | 103 | 0.050 |
Why?
|
| Fluoroscopy | 1 | 2023 | 64 | 0.050 |
Why?
|
| Cholangiocarcinoma | 1 | 2023 | 30 | 0.050 |
Why?
|
| Image-Guided Biopsy | 1 | 2023 | 42 | 0.050 |
Why?
|
| Life Style | 1 | 2024 | 311 | 0.050 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2024 | 225 | 0.050 |
Why?
|
| Posture | 1 | 2023 | 127 | 0.050 |
Why?
|
| Pain Management | 1 | 2024 | 161 | 0.050 |
Why?
|
| Societies, Medical | 1 | 2024 | 369 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2025 | 751 | 0.050 |
Why?
|
| Sutures | 1 | 2021 | 41 | 0.050 |
Why?
|
| Adult | 3 | 2025 | 16669 | 0.050 |
Why?
|
| Anticoagulants | 1 | 2024 | 495 | 0.040 |
Why?
|
| Equivalence Trials as Topic | 1 | 2019 | 4 | 0.040 |
Why?
|
| Costs and Cost Analysis | 1 | 2019 | 102 | 0.040 |
Why?
|
| Automation | 1 | 2019 | 54 | 0.040 |
Why?
|
| Unnecessary Procedures | 1 | 2018 | 44 | 0.040 |
Why?
|
| Medical Records | 1 | 2017 | 137 | 0.030 |
Why?
|
| Gastrointestinal Tract | 1 | 2018 | 181 | 0.030 |
Why?
|
| Length of Stay | 1 | 2019 | 806 | 0.030 |
Why?
|
| Recurrence | 1 | 2017 | 638 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 1594 | 0.020 |
Why?
|
| Massachusetts | 1 | 2017 | 2062 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 2553 | 0.020 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2008 | 7 | 0.020 |
Why?
|
| Biopsy | 1 | 2008 | 431 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 424 | 0.020 |
Why?
|